Growth Factor Targets for Orthodontic Treatments

Seminars in Orthodontics - Tập 16 - Trang 128-134 - 2010
Elisabeth R. Barton1, Charles Crowder2
1Department of Anatomy and Cell Biology, University of Pennsylvania, Philadelphia, PA
2Department of Orthodontics, School of Dental Medicine, University of Pennsylvania, Philadelphia, Pa

Tài liệu tham khảo

de Crombrugghe, 2001, Regulatory mechanisms in the pathways of cartilage and bone formation, Curr Opin Cell Biol, 13, 721, 10.1016/S0955-0674(00)00276-3 Moss, 1968, A theoretical analysis of the functional matrix, Acta Biotheor, 18, 195, 10.1007/BF01556727 Moss, 1968, The role of the functional matrix in mandibular growth, Angle Orthod, 38, 95 Moss, 1997, The functional matrix hypothesis revisited, Am J Orthod Dentofac Orthop, 112, 8, 10.1016/S0889-5406(97)70267-1 Ko, 2005, Cephalometric craniofacial characteristics in patients with temporomandibular joint ankylosis, Chang Gung Med J, 28, 456 Kecik, 2007, Evaluation of the treatment changes of functional posterior crossbite in the mixed dentition, Am J Orthod Dentofac Orthop, 131, 202, 10.1016/j.ajodo.2005.03.030 Mew, 1999, Nonsurgical rapid maxillary expansion in adults: Report on 47 cases, Angle Orthod, 70, 129 Ghafari, 1982, Condylar adaptation to muscle alteration in the rat, Angle Orthod, 52, 26 Ghafari, 1989, Condylar cartilage in the muscular dystrophic mouse, Am J Orthod Dentofac Orthop, 95, 107, 10.1016/0889-5406(89)90389-2 Ghafari, 1986, Condylar cartilage response to continuous mandibular displacement in the rat, Angle Orthod, 56, 49 Schwander, 1983, Synthesis and secretion of insulin-like growth factor and its binding protein by the perfused rat liver: Dependence on growth hormone status, Endocrinologist, 113, 297, 10.1210/endo-113-1-297 Firth, 2002, Cellular actions of the insulin-like growth factor binding proteins, Endocr Rev, 23, 824, 10.1210/er.2001-0033 Coolican, 1997, The mitogenic and myogenic actions of insulin-like growth factors utilize distinct signaling pathways, J Biol Chem, 272, 6653, 10.1074/jbc.272.10.6653 Liu, 1993, Mice carrying null mutations of the genes encoding insulin-like growth factor I (IGF-1) and type 1 IGF receptor (Igf1r), Cell, 75, 59 Baker, 1993, Role of insulin-like growth factors in embryonic and postnatal growth, Cell, 75, 73, 10.1016/0092-8674(93)90680-O Mathews, 1988, Growth enhancement of transgenic mice expressing human insulin-like growth factor I, Endocrinology, 123, 2827, 10.1210/endo-123-6-2827 Solheim, 1998, Growth factors in bone, Int Orthop, 22, 410, 10.1007/s002640050290 Spears, 2005, Growth factors and signaling proteins in craniofacial development, Semin Orthod, 11, 184, 10.1053/j.sodo.2005.07.003 Lindahl, 1987, Growth hormone in vivo potentiates the stimulatory effect of insulin-like growth factor-1 in vitro on colony formation of epiphyseal chondrocytes isolated from hypophysectomized rats, Endocrinologist, 121, 1070, 10.1210/endo-121-3-1070 Isaksson, 1991, Regulation of cartilage growth by growth hormone and insulin-like growth factor I, Pediatr Nephrol, 5, 451, 10.1007/BF01453680 Ohlsson, 1994, Clonal analysis of rat tibia growth plate chondrocytes in suspension culture—Differential effects of growth hormone and insulin-like growth factor I, Growth Regul, 4, 1 McAlarney, 2001, The quantitative and qualitative analysis of the craniofacial skeleton of mice lacking the IGF-1 gene, Clin Orthod Res, 4, 206, 10.1034/j.1600-0544.2001.40405.x Tokimasa, 2003, Effects of insulin-like growth factor-I on the expression of osteoclasts and osteoblasts in the nasopremaxillary suture under different masticatory loading conditions in growing mice, Arch Oral Biol, 48, 31, 10.1016/S0003-9969(02)00161-9 Kim, 2005, Intact insulin and insulin-like growth factor-I receptor signaling is required for growth hormone effects on skeletal muscle growth and function in vivo, Endocrinologist, 146, 1772, 10.1210/en.2004-0906 Florini, 1996, Growth hormone and the insulin-like growth factor system in myogenesis, Endocr Rev, 17, 481 Fernandez, 2002, Muscle-specific inactivation of the IGF-1 receptor induces compensatory hyperplasia in skeletal muscle, J Clin Invest, 109, 347, 10.1172/JCI0213503 Adams, 1998, Localized infusion of IGF-1 results in skeletal muscle hypertrophy in rats, J Appl Physiol, 84, 1716, 10.1152/jappl.1998.84.5.1716 Coleman, 1995, Myogenic vector expression of insulin-like growth factor I stimulates muscle cell differentiation and myofiber hypertrophy in transgenic mice, J Biol Chem, 270, 12109, 10.1074/jbc.270.20.12109 Musaro, 2001, Localized IGF-1 transgene expression sustains hypertrophy and regeneration in senescent skeletal muscle, Nat Genet, 27, 195, 10.1038/84839 Barton-Davis, 1998, Viral mediated expression of insulin-like growth factor I blocks the aging-related loss of skeletal muscle function, Proc Natl Acad Sci U S A, 95, 15603, 10.1073/pnas.95.26.15603 Barton, 2002, Muscle-specific expression of insulin-like growth factor I counters muscle decline in mdx mice, J Cell Biol, 157, 137, 10.1083/jcb.200108071 Lynch, 2001, IGF-1 treatment improves the functional properties of fast- and slow-twitch skeletal muscles from dystrophic mice, Neuromuscul Disord, 11, 260, 10.1016/S0960-8966(00)00192-9 Lee, 2004, Viral expression of insulin-like growth factor-I enhances muscle hypertrophy in resistance-trained rats, J Appl Physiol, 96, 1097, 10.1152/japplphysiol.00479.2003 Proffit, 2000 Doyle, 1970, Relation between bone mass and muscle weight, Lancet, 1, 391, 10.1016/S0140-6736(70)91520-5 Andreoli, 2001, Effects of different sports on bone density and muscle mass in highly trained athletes, Med Sci Sports Exerc, 33, 507, 10.1097/00005768-200104000-00001 Kaye, 1995, Genetic lineage, bone mass, and physical activity in mice, Bone, 17, 131, 10.1016/S8756-3282(00)00164-2 Schoenau, 2002, The “muscle-bone unit” in children and adolescents, Calcif Tissue Int, 70, 405, 10.1007/s00223-001-0048-8 Rauch, 2004, The “muscle-bone unit” during the pubertal growth spurt, Bone, 34, 771, 10.1016/j.bone.2004.01.022 Godfrey, 2003, The exercise-induced growth hormone response in athletes, Sports Med, 33, 599, 10.2165/00007256-200333080-00005 Yao, 2004, Increase of both angiogenesis and bone mass in response to exercise depends on VEGF, J Bone Miner Res, 19, 1471, 10.1359/JBMR.040517 McPherron, 1997, Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member, Nature, 387, 83, 10.1038/387083a0 Byron, 2006, Alterations of temporalis muscle contractile force and histological content from the myostatin and Mdx deficient mouse, Arch Oral Biol, 51, 396, 10.1016/j.archoralbio.2005.09.006 Vecchione, 2007, Craniofacial morphology in myostatin-deficient mice, J Dent Res, 86, 1068, 10.1177/154405910708601109 Borasio, 1998, A placebo-controlled trial of insulin-like growth factor-I in amyotrophic lateral sclerosis, Neurologist, 51, 583, 10.1212/WNL.51.2.583 Butterfield, 1997, Effect of rhGH and rhIGF-I treatment on protein utilization in elderly women, Am J Physiol, 272, E94 Cusi, 2000, Recombinant human insulin-like growth factor I treatment for 1 week improves metabolic control in type 2 diabetes by ameliorating hepatic and muscle insulin resistance, J Clin Endocrinol Metab, 85, 3077, 10.1210/jc.85.9.3077 Friedlander, 2001, One year of insulin-like growth factor I treatment does not affect bone density, body composition, or psychological measures in postmenopausal women, J Clin Endocrinol Metab, 86, 1496, 10.1210/jc.86.4.1496 Lai, 1997, Effect of recombinant human insulin-like growth factor-I on progression of ALS, Neurologist, 49, 1621, 10.1212/WNL.49.6.1621 Mauras, 2000, Insulin-like growth factor I and growth hormone (GH) treatment in GH-deficient humans: Differential effects on protein, glucose, lipid, and calcium metabolism, J Clin Endocrinol Metab, 85, 1686, 10.1210/jc.85.4.1686 Waters, 1996, Recombinant human growth hormone, insulin-like growth factor 1, and combination therapy in AIDS-associated wasting, Ann Intern Med, 125, 865, 10.7326/0003-4819-125-11-199612010-00001 Kemp, 2006, Efficacy and safety of mecasermin rinfabate, Exp Opin Biol Ther, 6, 533, 10.1517/14712598.6.5.533 Sjogren, 1999, Liver-derived insulin-like growth factor I (IGF-1) is the principal source of IGF-1 in blood but is not required for postnatal body growth in mice, Proc Natl Acad Sci U S A, 96, 7088, 10.1073/pnas.96.12.7088 Barton, 2006, Viral expression of insulin-like growth factor-I isoforms promotes different responses in skeletal muscle, J Appl Physiol, 100, 1778, 10.1152/japplphysiol.01405.2005